Corporate Banner
Satellite Banner
Technology Networks Header
Tuesday, July 22, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
DiaSorin Marks Significant Growth in Molecular Extraction Kit Sales
Friday, February 14, 2014
Italian Voden Medical Instruments S.p.A. awarded DiaSorin Platinum Distributor status.

Greiner Bio-One Presents Innovative Cryo.s Biobanking Tubes
Friday, February 14, 2014
An innovative solution for storing biological samples in biorepositories.

GenomOncology To Enable CompanionDxTM Clinical Cancer Panels
Monday, February 10, 2014
The GO Clinical WorkbenchTM is selected to launch a series of next generation sequencing (NGS)-based assays.

EKF Molecular to Showcase PointMan™ DNA-enrichment Kits
Monday, February 10, 2014
EKF Diagnostics’ subsidiary company is exhibiting its ground-breaking technology at Tri-Con 2014 in San Francisco, CA, Booth #417, 10-14th February.

Tecan Offers Cavro® Air Displacement Pipettor Option for Cavro Omni Robot
Friday, February 07, 2014
Provides even greater flexibility in instrument design.

ChartMaxx® Earns 2013 'Best in KLAS' for Healthcare DMI Software Products
Thursday, February 06, 2014
ChartMaxx enterprise content management system honored with top ranking for the ninth time.

Short Term Storage of Blood or Urine Samples
Thursday, February 06, 2014
Novitain TPE Push Caps offer an ideal solution for the secure short-term sealing of tubes.

Wako Life Sciences Receives AACC Award
Tuesday, February 04, 2014
Dr. Shinji Satomura and Dr. Henry Wada receives the award for the uTASWako i30 Immunoanalyzer.

First RayStation® Order in the United Kingdom
Saturday, February 01, 2014
Ninewells to be the first clinical installation of RayStation® in the United Kingdom.

<< 3 4 5 6 7 8 9 >>
Showing Results 51 - 60 of 438
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv